141 related articles for article (PubMed ID: 12757728)
21. Bisquaternary caracurine V derivatives as allosteric modulators of ligand binding to M2 acetylcholine receptors.
Zlotos DP; Buller S; Tränkle C; Mohr K
Bioorg Med Chem Lett; 2000 Nov; 10(22):2529-32. PubMed ID: 11086722
[TBL] [Abstract][Full Text] [Related]
22. Changes of cooperativity between N-methylscopolamine and allosteric modulators alcuronium and gallamine induced by mutations of external loops of muscarinic M(3) receptors.
Krejcí A; Tucek S
Mol Pharmacol; 2001 Oct; 60(4):761-7. PubMed ID: 11562438
[TBL] [Abstract][Full Text] [Related]
23. Interactions of orthosteric and allosteric ligands with [3H]dimethyl-W84 at the common allosteric site of muscarinic M2 receptors.
Tränkle C; Weyand O; Voigtländer U; Mynett A; Lazareno S; Birdsall NJ; Mohr K
Mol Pharmacol; 2003 Jul; 64(1):180-90. PubMed ID: 12815174
[TBL] [Abstract][Full Text] [Related]
24. Positive cooperativity of acetylcholine and other agonists with allosteric ligands on muscarinic acetylcholine receptors.
Jakubík J; Bacáková L; El-Fakahany EE; Tucek S
Mol Pharmacol; 1997 Jul; 52(1):172-9. PubMed ID: 9224827
[TBL] [Abstract][Full Text] [Related]
25. Allosteric site on muscarinic acetylcholine receptors: identification of two amino acids in the muscarinic M2 receptor that account entirely for the M2/M5 subtype selectivities of some structurally diverse allosteric ligands in N-methylscopolamine-occupied receptors.
Voigtländer U; Jöhren K; Mohr M; Raasch A; Tränkle C; Buller S; Ellis J; Höltje HD; Mohr K
Mol Pharmacol; 2003 Jul; 64(1):21-31. PubMed ID: 12815157
[TBL] [Abstract][Full Text] [Related]
26. Application of a kinetic model to the apparently complex behavior of negative and positive allosteric modulators of muscarinic acetylcholine receptors.
Avlani V; May LT; Sexton PM; Christopoulos A
J Pharmacol Exp Ther; 2004 Mar; 308(3):1062-72. PubMed ID: 14711931
[TBL] [Abstract][Full Text] [Related]
27. Detection, quantitation, and verification of allosteric interactions of agents with labeled and unlabeled ligands at G protein-coupled receptors: interactions of strychnine and acetylcholine at muscarinic receptors.
Lazareno S; Birdsall NJ
Mol Pharmacol; 1995 Aug; 48(2):362-78. PubMed ID: 7651370
[TBL] [Abstract][Full Text] [Related]
28. Analogs of WIN 62,577 define a second allosteric site on muscarinic receptors.
Lazareno S; Popham A; Birdsall NJ
Mol Pharmacol; 2002 Dec; 62(6):1492-505. PubMed ID: 12435818
[TBL] [Abstract][Full Text] [Related]
29. A novel multivalent ligand that bridges the allosteric and orthosteric binding sites of the M2 muscarinic receptor.
Steinfeld T; Mammen M; Smith JA; Wilson RD; Jasper JR
Mol Pharmacol; 2007 Aug; 72(2):291-302. PubMed ID: 17478612
[TBL] [Abstract][Full Text] [Related]
30. Development of a radioligand, [(3)H]LY2119620, to probe the human M(2) and M(4) muscarinic receptor allosteric binding sites.
Schober DA; Croy CH; Xiao H; Christopoulos A; Felder CC
Mol Pharmacol; 2014 Jul; 86(1):116-23. PubMed ID: 24807966
[TBL] [Abstract][Full Text] [Related]
31. Muscarinic allosteric modulators: atypical structure-activity-relationships in bispyridinium-type compounds.
Sürig U; Gaal K; Kostenis E; Tränkle C; Mohr K; Holzgrabe U
Arch Pharm (Weinheim); 2006 Apr; 339(4):207-12. PubMed ID: 16572483
[TBL] [Abstract][Full Text] [Related]
32. Divergent modes of action among cationic allosteric modulators of muscarinic M2 receptors.
Tränkle C; Mohr K
Mol Pharmacol; 1997 Apr; 51(4):674-82. PubMed ID: 9106634
[TBL] [Abstract][Full Text] [Related]
33. Contribution of lateral substituents in symmetrical and non-symmetrical heptane-bisammonio compounds to the allosteric stabilization of N-methylscopolamine binding to muscarinic M2 receptors.
Staudt M; Tränkle C; Mohr K; Holzgrabe U
Arch Pharm (Weinheim); 2003 Aug; 336(8):385-9. PubMed ID: 14502759
[TBL] [Abstract][Full Text] [Related]
34. Kinetic studies of co-operativity at atrial muscarinic M2 receptors with an "infinite dilution" procedure.
Christopoulos A; Lanzafame A; Ziegler A; Mitchelson F
Biochem Pharmacol; 1997 Mar; 53(6):795-800. PubMed ID: 9113100
[TBL] [Abstract][Full Text] [Related]
35. Effects of brucine, a plant alkaloid, on M(1) muscarinic receptors and alpha(1)-adrenoceptors in the rabbit vas deferens preparation.
Bradley KN; Rowan EG; Harvey AL
Toxicon; 2001 Apr; 39(4):581-7. PubMed ID: 11024498
[TBL] [Abstract][Full Text] [Related]
36. Structure-activity relationships in a series of bisquaternary bisphthalimidine derivatives modulating the muscarinic M(2)-receptor allosterically.
Botero Cid HM; Tränkle C; Baumann K; Pick R; Mies-Klomfass E; Kostenis E; Mohr K; Holzgrabe U
J Med Chem; 2000 Jun; 43(11):2155-64. PubMed ID: 10841794
[TBL] [Abstract][Full Text] [Related]
37. Interaction of Mg2+ with the allosteric site of muscarinic M2 receptors.
Burgmer U; Schulz U; Tränkle C; Mohr K
Naunyn Schmiedebergs Arch Pharmacol; 1998 Apr; 357(4):363-70. PubMed ID: 9606020
[TBL] [Abstract][Full Text] [Related]
38. Characterization of methanthelinium binding and function at human M
Irmen M; Holze J; Bödefeld T; Tränkle C
Naunyn Schmiedebergs Arch Pharmacol; 2018 Oct; 391(10):1037-1052. PubMed ID: 29938305
[TBL] [Abstract][Full Text] [Related]
39. Contribution of lateral substituents in heptane-bisammonium derivatives to the allosteric stabilization of antagonist binding to M2-receptors.
Staudt M; Tränkle C; Mohr K; Holzgrabe U
Life Sci; 1998; 62(5):423-9. PubMed ID: 9449232
[TBL] [Abstract][Full Text] [Related]
40. Search for the pharmacophore of bispyridinium-type allosteric modulators of muscarinic receptors.
Botero Cid MH; Holzgrabe U; Kostenis E; Mohr K; Tränkle C
J Med Chem; 1994 May; 37(10):1439-45. PubMed ID: 8182702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
